zafirlukast (Zafirlukast) (Tablet) 10 mg/1

Zafirlukast 10 mg tablets are a prescription leukotriene receptor antagonist used to manage asthma symptoms in adults and children. This non-steroidal oral medication helps reduce inflammation in the airways. It is not a rescue inhaler for sudden breathing problems.

Strength

10 mg/1

Manufacturer / TM Owner

Par Pharmaceutical, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zafirlukast 10 mg tablets are commonly prescribed to prevent and control chronic asthma symptoms in adults and children aged 5 and older. It works by blocking leukotrienes, substances in the body that tighten airway muscles and cause swelling. People often ask, 'what is zafirlukast used for?' to manage persistent asthma and reduce the frequency of asthma attacks when taken regularly.

Side Effects

Zafirlukast 10 mg tablets may help reduce wheezing, shortness of breath, and chest tightness associated with asthma. Users may notice improved breathing and fewer nighttime awakenings due to asthma symptoms. Effects can vary, and it may take time to see full benefits.

Precautions & Warnings

Store zafirlukast 10 mg tablets at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the blister pack is torn or the tablets appear damaged. If you are pregnant, planning pregnancy, or breastfeeding, consult a healthcare professional before use.

Avoid Interactions

Zafirlukast may interact with certain medications, including blood thinners like warfarin and some antibiotics such as erythromycin. Avoid taking zafirlukast with food, especially high-fat meals, as this can reduce absorption. Alcohol use may enhance drowsiness or dizziness; consult a healthcare provider for personalized advice.

Frequently Asked Questions

Zafirlukast 10 mg tablets are used to prevent and control chronic asthma symptoms in adults and children aged 5 and older.

Effects may be noticed within a few days, but full benefits can take several weeks of regular use.

No, zafirlukast should be taken on an empty stomach, at least 1 hour before or 2 hours after meals.

No, zafirlukast is a non-steroidal leukotriene receptor antagonist used to manage asthma symptoms.

Take the missed dose as soon as you remember, but skip it if it is almost time for the next dose.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.